Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Petmed Express Inc | Douglas Krulik | CAO and Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2026 | 32,500 | 102,500 (0%) | 0% | 0 | Common Stock | |
| Petmed Express Inc | Douglas Krulik | CAO and Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2026 | 32,500 | 32,500 | - | - | Performance Share Units | |
| Alignment Healthcare Inc | Joseph Konowiecki | Director, EVP, Corporate Affairs | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 26 Jun 2026 | 25,000 | 1,128,816 | - | 23 | 575,000 | Common Stock |
| Genuine Parts | Christopher T. Galla | SVP, GC, and Corp. Secretary | Sale of securities on an exchange or to another person at price $ 115.00 per share. | 26 Jun 2026 | 2,333 | 21,969 (0%) | 0% | 115 | 268,295 | Common Stock |
| ProFrac Holding Corp (Class A) | Farris Wilks | Ten Percent Owner | Other type of transaction at price $ 4.72 per share. | 25 Jun 2026 | 1,071,454 | 1,071,454 | - | 4.7 | 5,057,263 | Series A common stock, par value $0.01 per share |
| SharkNinja Inc | Mark Barrocas | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 145.00 per share. | 25 Jun 2026 | 100,000 | 2,246,659 | - | 145 | 14,500,000 | Ordinary Shares |
| Orix Corp (ADR) | Hidetake Takahashi | Director, See remarks | Other type of transaction at price $ 0.00 per share. | 25 Jun 2026 | 81,560 | 264,046 | - | - | Share-based Compensation Points | |
| Vodafone Grp PLC (ADR) | Maria Pilar Lopez Alvarez | Executive Director,Group Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.05 per share. | 25 Jun 2026 | 57,194 | 3,495,747 (0%) | 0% | 1.1 | 60,125 | Ords 1.15p |
| Curbline Properties Corp | Conor M. Fennerty | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 49,326 | 209,014 | - | 0 | Common Stock | |
| Curbline Properties Corp | John M. Cattonar | EVP & Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 45,051 | 183,189 | - | 0 | Common Stock | |
| Medallion Fin Corp | Donald S. Poulton | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.97 per share. | 25 Jun 2026 | 40,770 | 278,247 (1%) | 0% | 10.0 | 406,477 | Common Stock |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 20.06 per share. | 25 Jun 2026 | 28,935 | 13,579 | - | 20.1 | 580,506 | Common Stock |
| Archrock Inc | D. Bradley Childers | Director, PRESIDENT AND CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Jun 2026 | 25,000 | 2,300,647 (1%) | 0% | 0 | Common Stock | |
| Clean Energy Fuels Corp | Stephen A. Scully | Director | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 25 Jun 2026 | 25,000 | 360,244 (0%) | 0% | 1.7 | 43,725 | Common Stock |
| MGIC Investment Corp | Nathaniel H. Colson | Officer EVP, CFO & CRO | Sale of securities on an exchange or to another person at price $ 27.10 per share. | 25 Jun 2026 | 20,000 | 341,225 (0%) | 0% | 27.1 | 542,000 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 25 Jun 2026 | 18,880 | 824,039 (2%) | 0% | 95 | 1,793,600 | Common Stock |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2026 | 15,602 | 134,398 | - | - | Employee Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.72 per share. | 25 Jun 2026 | 15,602 | 42,514 | - | 8.7 | 136,049 | Common Stock |
| Globe Life | Cheryl D. Alston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2026 | 14,017 | 0 | - | - | Director Stock Option (Right to Buy) | |
| Globe Life | Cheryl D. Alston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 105.56 per share. | 25 Jun 2026 | 14,017 | 24,879 (0%) | 0% | 105.6 | 1,479,635 | Common Stock |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.26 per share. | 25 Jun 2026 | 13,333 | 26,912 | - | 7.3 | 96,798 | Common Stock |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2026 | 13,333 | 0 | - | - | Employee Stock Option (right to buy) | |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.46 per share. | 25 Jun 2026 | 12,518 | 271,435 (0%) | 0% | 30.5 | 381,298 | Common Stock |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2026 | 12,518 | 12,519 | - | - | Stock Option (right to buy) | |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 102.34 per share. | 25 Jun 2026 | 12,091 | 268,224 (0%) | 0% | 102.3 | 1,237,393 | Common Stock |
| Macy`s Inc | Paul Griscom | SVP and Controller | Sale of securities on an exchange or to another person at price $ 25.63 per share. | 25 Jun 2026 | 10,077 | 25,373 (0%) | 0% | 25.6 | 258,278 | Common Stock |
| Journey Medical Corp | Lindsay A. Rosenwald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 10,000 | 221,146 | - | 0 | Common Stock, $0.0001 par value | |
| Journey Medical Corp | Neil Herskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 10,000 | 118,618 | - | 0 | Common Stock, $0.0001 par value | |
| Journey Medical Corp | Michael C. Pearce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 10,000 | 67,173 | - | 0 | Common Stock, $0.0001 par value | |
| Journey Medical Corp | Justin Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 10,000 | 181,618 | - | 0 | Common Stock, $0.0001 par value | |
| Viemed Healthcare Inc | William Frazier | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2026 | 10,000 | 26,261 | - | - | Stock Options | |
| Viemed Healthcare Inc | William Frazier | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.81 per share. | 25 Jun 2026 | 10,000 | 83,214 | - | 1.8 | 18,100 | Common Shares |
| Viemed Healthcare Inc | William Frazier | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.72 per share. | 25 Jun 2026 | 10,000 | 73,214 | - | 11.7 | 117,200 | Common Shares |
| Fidelity National Fin Inc | Halim Dhanidina | Director | Sale of securities on an exchange or to another person at price $ 418.25 per share. | 25 Jun 2026 | 9,543 | 3,643 (0%) | 0% | 418.3 | 3,991,360 | Common Stock |
| Ampco-Pittsburgh Corp | Samuel C. Lyon | President of Union Electric | Sale of securities on an exchange or to another person at price $ 9.82 per share. | 25 Jun 2026 | 9,500 | 181,233 (1%) | 0% | 9.8 | 93,267 | Common Stock |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2026 | 8,880 | 8,880 | - | - | Stock Option (right to buy) | |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.16 per share. | 25 Jun 2026 | 8,880 | 280,315 (0%) | 0% | 17.2 | 152,381 | Common Stock |
| 908 Devices Inc | Michele M. Leonhart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2026 | 6,486 | 27,054 | - | - | Common Stock | |
| 908 Devices Inc | Michele M. Leonhart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2026 | 6,486 | 6,485 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 25 Jun 2026 | 5,394 | 115,005 | - | 20 | 107,880 | Common Stock |
| Kymera Therapeutics Inc | Noah Goodman | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.05 per share. | 25 Jun 2026 | 5,000 | 55,195 | - | 21.1 | 105,250 | Common Stock |
| Kymera Therapeutics Inc | Noah Goodman | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2026 | 5,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Tortoise Energy infra Corp | Conrad S. Ciccotello | Director | Purchase of securities on an exchange or from another person at price $ 42.24 per share. | 25 Jun 2026 | 4,056 | 16,225 (0%) | 0% | 42.2 | 171,325 | Common Shares |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 104.28 per share. | 25 Jun 2026 | 3,723 | 262,665 (0%) | 0% | 104.3 | 388,234 | Common Stock |
| Worthington Ind Inc | Patrick J. Kennedy | VP-General Counsel & Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 3,630 | 32,952 (0%) | 0% | 0 | Common Shares | |
| Worthington Ind Inc | Colin J. Souza | VP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 2,990 | 20,890 (0%) | 0% | 0 | Common Shares | |
| Worthington Ind Inc | Steven M. Caravati | President - Consumer Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 2,880 | 45,519 (0%) | 0% | 0 | Common Shares | |
| Valvoline Inc | Jonathan L. Caldwell | Chief People Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 25 Jun 2026 | 2,851 | 20,918 (0%) | 0% | 40 | 114,040 | Common Stock |
| Globe Life | Cheryl D. Alston | Director | Sale of securities on an exchange or to another person at price $ 177.56 per share. | 25 Jun 2026 | 2,750 | 22,129 (0%) | 0% | 177.6 | 488,292 | Common Stock |
| Worthington Ind Inc | James R. Bowes | President - Building Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 2,620 | 17,784 (0%) | 0% | 0 | Common Shares | |
| Globe Life | Cheryl D. Alston | Director | Sale of securities on an exchange or to another person at price $ 180.57 per share. | 25 Jun 2026 | 2,564 | 16,621 (0%) | 0% | 180.6 | 462,981 | Common Stock |
| Kymera Therapeutics Inc | Noah Goodman | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 119.00 per share. | 25 Jun 2026 | 2,500 | 50,195 | - | 119 | 297,500 | Common Stock |
| Kymera Therapeutics Inc | Noah Goodman | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 109.00 per share. | 25 Jun 2026 | 2,500 | 52,695 | - | 109 | 272,500 | Common Stock |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 105.27 per share. | 25 Jun 2026 | 2,456 | 260,209 (0%) | 0% | 105.3 | 258,543 | Common Stock |
| Dyne Therapeutics Inc | Erick J. Lucera | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.37 per share. | 25 Jun 2026 | 2,362 | 121,563 | - | 20.4 | 48,114 | Common Stock |
| Farmland Partners Inc | Bruce J. Sherrick | Director | Purchase of securities on an exchange or from another person at price $ 9.65 per share. | 25 Jun 2026 | 2,000 | 33,726 (0%) | 0% | 9.7 | 19,300 | Common Stock |
| CarMax | Sona Chawla | Director | Purchase of securities on an exchange or from another person at price $ 53.39 per share. | 25 Jun 2026 | 2,000 | 21,702 (0%) | 0% | 53.4 | 106,780 | Common Stock |
| Globe Life | Cheryl D. Alston | Director | Sale of securities on an exchange or to another person at price $ 180.13 per share. | 25 Jun 2026 | 1,934 | 19,185 (0%) | 0% | 180.1 | 348,364 | Common Stock |
| Williams Companies | John D. Porter | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2026 | 1,899 | 0 | - | - | Employee Options (Right to Buy) | |
| Williams Companies | John D. Porter | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.98 per share. | 25 Jun 2026 | 1,899 | 198,466 (0%) | 0% | 25.0 | 47,437 | Common Stock |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 103.10 per share. | 25 Jun 2026 | 1,836 | 266,388 (0%) | 0% | 103.1 | 189,292 | Common Stock |
| NewtekOne Inc | Thomas D. Cestare | Director | Grant, award, or other acquisition of securities at price $ 13.70 per share. | 25 Jun 2026 | 1,825 | 1,895 (0%) | 0% | 13.7 | 25,003 | Common Stock |
| Worthington Ind Inc | Colin J. Souza | VP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 1,630 | 22,520 (0%) | 0% | 0 | Common Shares | |
| Worthington Ind Inc | Steven M. Caravati | President - Consumer Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 1,600 | 47,119 (0%) | 0% | 0 | Common Shares | |
| TREX Co. Inc | Jacob T. Rudolph | SVP, CHRO | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 25 Jun 2026 | 1,400 | 36,631 (0%) | 0% | 50 | 70,000 | Common Stock |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 106.27 per share. | 25 Jun 2026 | 1,292 | 258,917 (0%) | 0% | 106.3 | 137,301 | Common Stock |
| Williams Companies | John D. Porter | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.62 per share. | 25 Jun 2026 | 1,176 | 197,290 (0%) | 0% | 77.6 | 91,281 | Common Stock |
| Worthington Ind Inc | James R. Bowes | President - Building Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 1,150 | 19,934 (0%) | 0% | 0 | Common Shares | |
| Globe Life | Cheryl D. Alston | Director | Sale of securities on an exchange or to another person at price $ 178.71 per share. | 25 Jun 2026 | 1,010 | 21,119 (0%) | 0% | 178.7 | 180,497 | Common Stock |
| Worthington Ind Inc | James R. Bowes | President - Building Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 1,000 | 18,784 (0%) | 0% | 0 | Common Shares | |
| Worthington Ind Inc | Colin J. Souza | VP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 810 | 23,330 (0%) | 0% | 0 | Common Shares | |
| Worthington Ind Inc | Patrick J. Kennedy | VP-General Counsel & Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 760 | 33,712 (0%) | 0% | 0 | Common Shares | |
| Repligen Corp | Jason K. Garland | CFO | Sale of securities on an exchange or to another person at price $ 145.00 per share. | 25 Jun 2026 | 733 | 19,359 (0%) | 0% | 145 | 106,285 | Common Stock |
| Illumina Inc | Scott M. Davies | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 180.00 per share. | 25 Jun 2026 | 615 | 20,953 (0%) | 0% | 180 | 110,700 | Common Stock |
| CarMax | Marcella Shinder | Director | Purchase of securities on an exchange or from another person at price $ 52.01 per share. | 25 Jun 2026 | 574 | 24,993 (0%) | 0% | 52.0 | 29,854 | Common Stock |
| Worthington Ind Inc | James R. Bowes | President - Building Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 570 | 20,504 (0%) | 0% | 0 | Common Shares | |
| Citizens Fin Services Inc | Randall E. Black | Director, CEO & PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 563 | 46,486 (1%) | 0% | 0 | COMMON CLASS | |
| Worthington Ind Inc | Patrick J. Kennedy | VP-General Counsel & Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 380 | 34,092 (0%) | 0% | 0 | Common Shares | |
| Citizens Fin Services Inc | Jeffrey R. White | EXECUTIVE VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 336 | 2,010 (0%) | 0% | 0 | COMMON CLASS | |
| Citizens Fin Services Inc | Stephen J. Guillaume | EXECUTIVE VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 311 | 5,029 (0%) | 0% | 0 | COMMON CLASS | |
| Kroger | Mitchell R. Butier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 289 | 289 (0%) | 0% | 0 | Common Stock | |
| RBC Bearings Inc | John J. Feeney | Vice President and Secretary | Sale of securities on an exchange or to another person at price $ 657.94 per share. | 25 Jun 2026 | 225 | 2,378 (0%) | 0% | 657.9 | 148,037 | Common Stock |
| Worthington Ind Inc | Steven M. Caravati | President - Consumer Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 210 | 47,329 (0%) | 0% | 0 | Common Shares | |
| Citizens Fin Services Inc | LeeAnn Gephart | EXECUTIVE VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 153 | 961 (0%) | 0% | 0 | COMMON CLASS | |
| Ritchie Bros Auctioneers Inc | Christopher Carlson | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 115.00 per share. | 25 Jun 2026 | 150 | 3,514 (0%) | 0% | 115 | 17,250 | Common Shares |
| Worthington Ind Inc | Steven M. Caravati | President - Consumer Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 100 | 47,429 (0%) | 0% | 0 | Common Shares | |
| Tortoise Energy infra Corp | Conrad S. Ciccotello | Director | Purchase of securities on an exchange or from another person at price $ 42.24 per share. | 25 Jun 2026 | 51 | 206 (0%) | 0% | 42.2 | 2,154 | Common Shares |
| Citizens Fin Services Inc | Jeffrey Wilson | EXECUTIVE VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 49 | 8,337 (0%) | 0% | 0 | COMMON CLASS | |
| Barings Corporate Investors | Christina Emery | President | Other type of transaction at price $ 0.00 per share. | 25 Jun 2026 | 43 | 6,894 | - | - | Barings Non-Qualified Thrift Plan | |
| Citizens Fin Services Inc | LeeAnn Gephart | EXECUTIVE VICE PRESIDENT | Sale of securities on an exchange or to another person at price $ 66.52 per share. | 25 Jun 2026 | 29 | 808 (0%) | 0% | 66.5 | 1,929 | COMMON CLASS |
| Valvoline Inc | Lori Ann Flees | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 24 | 15,577 | - | - | Deferred Stock Units | |
| Vertiv Holdings Co (Class A) | Giordano Albertazzi | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 9 | 166,110 (0%) | 0% | 0 | Class A Common Stock | |
| Vertiv Holdings Co (Class A) | Stephanie L. Gill | Chief Legal Officer & Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 4 | 34,429 (0%) | 0% | 0 | Class A Common Stock | |
| Vertiv Holdings Co (Class A) | Scott Armul | Chief Product and Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 4 | 32,037 (0%) | 0% | 0 | Class A Common Stock | |
| Vertiv Holdings Co (Class A) | Anand Sanghi | Pres. Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 3 | 36,368 (0%) | 0% | 0 | Class A Common Stock | |
| Vertiv Holdings Co (Class A) | Anders Karlborg | EVP, Man., Logistics and Op Ex | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 3 | 34,610 (0%) | 0% | 0 | Class A Common Stock | |
| Vertiv Holdings Co (Class A) | Paul Ryan | President EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 2 | 18,631 (0%) | 0% | 0 | Class A Common Stock | |
| Vertiv Holdings Co (Class A) | Frank Poncheri | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 2 | 16,659 (0%) | 0% | 0 | Class A Common Stock | |
| Vertiv Holdings Co (Class A) | Craig Chamberlin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 1 | 5,597 (0%) | 0% | 0 | Class A Common Stock | |
| Centessa Pharma PLC (ADR) | Francesco De Rubertis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 11,197,303 | 0 | - | - | Ordinary Shares | |
| Centessa Pharma PLC (ADR) | Francesco De Rubertis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 4,398,519 | 0 | - | - | Ordinary Shares | |
| Centessa Pharma PLC (ADR) | Francesco De Rubertis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 3,936,970 | 0 | - | - | Ordinary Shares | |
| Centessa Pharma PLC (ADR) | John Crowley | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 600,000 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Gregory M. Weinhoff | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 584,321 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Arjun Goyal | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 462,585 | 0 | - | - | Ordinary Shares | |
| DPC Holdings PLC | Michael Joseph Quinn | Director, CEO & Executive Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 458,470 | 458,470 | - | - | Share Options (right to buy) | |
| DPC Holdings PLC | Michael Joseph Quinn | Director, CEO & Executive Director | Purchase of securities on an exchange or from another person at price $ 33.00 per share. | 24 Jun 2026 | 435,121 | 435,121 | - | 33 | 14,358,993 | Ordinary Shares |
| Mountain Crest Acquisition 6 | Suying Liu | Director, CEO and CFO, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 24 Jun 2026 | 385,714 | 2,596,429 | - | - | Ordinary shares | |
| Centessa Pharma PLC (ADR) | Tia Bush | Chief Technology & Quality Ofc | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 360,338 | 0 | - | - | Share Option (right to buy) | |
| DPC Holdings PLC | Michael Joseph Quinn | Director, CEO & Executive Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 334,829 | 334,829 | - | - | Share Options (right to buy) | |
| DPC Holdings PLC | Michael Joseph Quinn | Director, CEO & Executive Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 334,829 | 334,829 | - | - | Share Options (right to buy) | |
| DPC Holdings PLC | Michael Joseph Quinn | Director, CEO & Executive Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 334,829 | 334,829 | - | - | Share Options (right to buy) | |
| DPC Holdings PLC | Michael Joseph Quinn | Director, CEO & Executive Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 334,829 | 334,829 | - | - | Share Options (right to buy) | |
| DPC Holdings PLC | Michael Joseph Quinn | Director, CEO & Executive Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 334,828 | 334,828 | - | - | Share Options (right to buy) | |
| Centessa Pharma PLC (ADR) | Gregory M. Weinhoff | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 319,660 | 0 | - | - | Share Option (right to buy) | |
| DPC Holdings PLC | Nicholas Sanders | Director | Purchase of securities on an exchange or from another person at price $ 33.00 per share. | 24 Jun 2026 | 288,213 | 288,213 | - | 33 | 9,511,029 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Francesco De Rubertis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 281,162 | 0 | - | - | Ordinary Shares | |
| DPC Holdings PLC | David John Egan | Director, CFO & Executive Director | Purchase of securities on an exchange or from another person at price $ 33.00 per share. | 24 Jun 2026 | 275,363 | 294,529 | - | 33 | 9,086,979 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 273,000 | 0 | - | - | Share Option (right to buy) | |
| Sacks Parente Golf Inc | Akinobu Yorihiro | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 261,780 | 498,870 | - | 0 | Common Stock | |
| Sacks Parente Golf Inc | Jeffrey R. Clayborne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 251,902 | 438,450 | - | 0 | Common Stock | |
| Centessa Pharma PLC (ADR) | John Crowley | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 250,000 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 243,282 | 0 | - | - | Ordinary Shares | |
| Centessa Pharma PLC (ADR) | Gregory M. Weinhoff | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 230,000 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 225,000 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Iqbal Hussain | Chief Legal Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 221,559 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Mary Lynne Hedley | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 208,474 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Samarth Kulkarni | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 208,474 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Carol Stuckley | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 208,474 | 0 | - | - | Share Option (right to buy) | |
| DPC Holdings PLC | David John Egan | Director, CFO & Executive Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 203,804 | 203,804 | - | - | Share Options (right to buy) | |
| DPC Holdings PLC | David John Egan | Director, CFO & Executive Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 200,419 | 200,419 | - | - | Share Options (right to buy) | |
| DPC Holdings PLC | David John Egan | Director, CFO & Executive Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 200,418 | 200,418 | - | - | Share Options (right to buy) | |
| DPC Holdings PLC | David John Egan | Director, CFO & Executive Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 200,418 | 200,418 | - | - | Share Options (right to buy) | |
| DPC Holdings PLC | David John Egan | Director, CFO & Executive Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 200,418 | 200,418 | - | - | Share Options (right to buy) | |
| DPC Holdings PLC | David John Egan | Director, CFO & Executive Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 200,418 | 200,418 | - | - | Share Options (right to buy) | |
| Centessa Pharma PLC (ADR) | John Crowley | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 181,000 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Iqbal Hussain | Chief Legal Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 175,000 | 0 | - | - | Share Option (right to buy) | |
| Kaltura Inc | Gregory C. Dracon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 170,594 | 178,658 | - | - | Common Stock | |
| Centessa Pharma PLC (ADR) | Iqbal Hussain | Chief Legal Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 170,000 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Iqbal Hussain | Chief Legal Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 166,779 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Raphael Deferiere | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 165,000 | 0 | - | - | Share Option (right to buy) | |
| DPC Holdings PLC | Jason Mays | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 160,718 | 160,718 | - | - | Share Options (right to buy) | |
| DPC Holdings PLC | Jason Mays | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 160,718 | 160,718 | - | - | Share Options (right to buy) | |
| DPC Holdings PLC | Jason Mays | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 160,718 | 160,718 | - | - | Share Options (right to buy) | |
| DPC Holdings PLC | Jason Mays | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 160,718 | 160,718 | - | - | Share Options (right to buy) | |
| DPC Holdings PLC | Jason Mays | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 160,717 | 160,717 | - | - | Share Options (right to buy) | |
| Centessa Pharma PLC (ADR) | Iqbal Hussain | Chief Legal Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 160,000 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Iqbal Hussain | Chief Legal Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 160,000 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Tia Bush | Chief Technology & Quality Ofc | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 147,954 | 0 | - | - | Ordinary Shares | |
| Centessa Pharma PLC (ADR) | Tia Bush | Chief Technology & Quality Ofc | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 145,208 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Tia Bush | Chief Technology & Quality Ofc | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 140,000 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Tia Bush | Chief Technology & Quality Ofc | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 140,000 | 0 | - | - | Share Option (right to buy) | |
| DPC Holdings PLC | Jason Mays | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 135,869 | 135,869 | - | - | Share Options (right to buy) | |
| Kaltura Inc | Ronen Faier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 133,333 | 583,039 | - | - | Common Stock | |
| Kaltura Inc | Richard Levandov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 133,333 | 623,039 | - | - | Common Stock | |
| Kaltura Inc | Shay David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 133,333 | 1,579,926 | - | - | Common Stock | |
| Kaltura Inc | Naama Halevi Davidov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 133,333 | 340,095 | - | - | Common Stock | |
| DPC Holdings PLC | Nicholas Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 127,989 | 127,989 | - | - | Share Options (right to buy) | |
| Centessa Pharma PLC (ADR) | Gregory M. Weinhoff | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 125,000 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Tia Bush | Chief Technology & Quality Ofc | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 125,000 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Gregory M. Weinhoff | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 123,000 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Karen Anderson | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 120,000 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Iqbal Hussain | Chief Legal Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 117,645 | 0 | - | - | Ordinary Shares | |
| Centessa Pharma PLC (ADR) | Karen Anderson | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 117,000 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Gregory M. Weinhoff | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 100,000 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Iqbal Hussain | Chief Legal Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 100,000 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Iqbal Hussain | Chief Legal Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 100,000 | 0 | - | - | Share Option (right to buy) | |
| Stitch Fix Inc (Class A) | Anthony Bacos | Chief Prod/Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 24 Jun 2026 | 100,000 | 1,171,994 (2%) | 0% | 4.0 | 399,000 | Class A Common Stock |
| Stitch Fix Inc (Class A) | Anthony Bacos | Chief Prod/Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2026 | 100,000 | 502,543 | - | - | Employee Stock Option (Right to Buy) | |
| Stitch Fix Inc (Class A) | Anthony Bacos | Chief Prod/Technology Officer | Sale of securities on an exchange or to another person at price $ 4.51 per share. | 24 Jun 2026 | 100,000 | 1,071,994 (1%) | 0% | 4.5 | 450,570 | Class A Common Stock |
| Telos Corp | Gary Mark Bendza | EVP, CFO | Sale of securities on an exchange or to another person at price $ 4.19 per share. | 24 Jun 2026 | 97,976 | 817,148 | - | 4.2 | 410,519 | Common Stock |
| Etsy Inc | Joshua G. Silverman | Director, Executive Chair of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.62 per share. | 24 Jun 2026 | 97,389 | 228,083 (0%) | 0% | 10.6 | 1,034,271 | Common Stock |
| Etsy Inc | Joshua G. Silverman | Director, Executive Chair of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2026 | 97,389 | 220,008 | - | - | Employee Stock Option (Right to Buy) | |
| Etsy Inc | Joshua G. Silverman | Director, Executive Chair of the Board | Sale of securities on an exchange or to another person at price $ 79.00 per share. | 24 Jun 2026 | 97,389 | 130,694 (0%) | 0% | 79 | 7,693,731 | Common Stock |
| Domo Inc (Class B) | Joshua G. James | Director, Founder and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.38 per share. | 24 Jun 2026 | 96,088 | 1,638,873 (6%) | 0% | 2.4 | 228,459 | Class B Common Stock |
| Centessa Pharma PLC (ADR) | Mathias Hukkelhoven | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 96,000 | 0 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Francesco De Rubertis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 93,526 | 0 | - | - | Ordinary Shares | |
| SL Green Realty Corp | Marc Holliday | Director, PRESIDENT & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 92,025 | 1,524,548 | - | - | LTIP Units | |
| Sunstone Hotel Investors Inc | Robert C. Springer | PRESIDENT AND CIO | Sale of securities on an exchange or to another person at price $ 11.62 per share. | 24 Jun 2026 | 89,631 | 573,743 (0%) | 0% | 11.6 | 1,041,512 | Common Stock |
| DPC Holdings PLC | Jason Mays | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 33.00 per share. | 24 Jun 2026 | 85,973 | 93,456 | - | 33 | 2,837,109 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Karen Anderson | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 83,924 | 0 | - | - | Share Option (right to buy) | |
| Telos Corp | Gary Mark Bendza | EVP, CFO | Sale of securities on an exchange or to another person at price $ 4.41 per share. | 24 Jun 2026 | 80,140 | 737,008 | - | 4.4 | 353,417 | Common Stock |
| Centessa Pharma PLC (ADR) | Karen Anderson | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 75,000 | 0 | - | - | Share Option (right to buy) | |
| Urban One Inc (Class A) | Peter D. Thompson | CFO/EVP | Sale or transfer of securities back to the company at price $ 4.50 per share. | 24 Jun 2026 | 72,655 | 38,293 (0%) | 0% | 4.5 | 326,948 | Class D Common Stock |
| Telos Corp | Gary Mark Bendza | EVP, CFO | Sale of securities on an exchange or to another person at price $ 4.36 per share. | 24 Jun 2026 | 71,884 | 915,124 | - | 4.4 | 313,414 | Common Stock |
| Horace Mann Educators Corp | Marita Zuraitis | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2026 | 71,532 | 0 | - | - | Employee Stock Option (right to buy) | |
| Horace Mann Educators Corp | Marita Zuraitis | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.95 per share. | 24 Jun 2026 | 71,532 | 386,089 (0%) | 0% | 42.9 | 3,072,299 | Common Stock |
| Horace Mann Educators Corp | Marita Zuraitis | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.95 per share. | 24 Jun 2026 | 70,424 | 378,235 (0%) | 0% | 42.0 | 2,954,287 | Common Stock |
| Horace Mann Educators Corp | Marita Zuraitis | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2026 | 70,424 | 0 | - | - | Employee Stock Option (right to buy) | |
| Domo Inc (Class B) | Tod Crane | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.38 per share. | 24 Jun 2026 | 68,483 | 276,809 (1%) | 0% | 2.4 | 162,825 | Class B Common Stock |
| Centessa Pharma PLC (ADR) | Gregory M. Weinhoff | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 65,925 | 0 | - | - | Ordinary Shares | |
| Horace Mann Educators Corp | Marita Zuraitis | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.75 per share. | 24 Jun 2026 | 65,465 | 320,624 (0%) | 0% | 50.8 | 3,322,349 | Common Stock |
| Centessa Pharma PLC (ADR) | Arjun Goyal | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 64,570 | 0 | - | - | Share Option (right to buy) | |
| Horace Mann Educators Corp | Marita Zuraitis | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.75 per share. | 24 Jun 2026 | 63,678 | 314,557 (0%) | 0% | 50.8 | 3,231,659 | Common Stock |
| Sacks Parente Golf Inc | Brett Hoge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 62,975 | 356,225 | - | 0 | Common Stock | |
| Centessa Pharma PLC (ADR) | Karen Anderson | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 62,085 | 0 | - | - | Ordinary Shares | |
| DPC Holdings PLC | Taiwo Danmola | Director | Purchase of securities on an exchange or from another person at price $ 33.00 per share. | 24 Jun 2026 | 60,604 | 60,604 | - | 33 | 1,999,932 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Francesco De Rubertis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 55,677 | 0 | - | - | Ordinary Shares | |
| Domo Inc (Class B) | Daren Thayne | CTO & EVP of Product | Sale of securities on an exchange or to another person at price $ 2.38 per share. | 24 Jun 2026 | 52,365 | 498,051 (2%) | 0% | 2.4 | 124,503 | Class B Common Stock |
| Centessa Pharma PLC (ADR) | Mary Lynne Hedley | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2026 | 48,000 | 0 | - | - | Share Option (right to buy) |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.